Other Liabilities - Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) - Alpha Spread
F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 17.97 CNY -2.5% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

Fujian Cosunter Pharmaceutical Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fujian Cosunter Pharmaceutical Co Ltd
Other Liabilities Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
F
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Other Liabilities
ÂĄ277.3m
CAGR 3-Years
81%
CAGR 5-Years
40%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Liabilities
ÂĄ22m
CAGR 3-Years
-2%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Liabilities
ÂĄ94.5m
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
14%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Liabilities
ÂĄ42.6m
CAGR 3-Years
-35%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Liabilities
ÂĄ892.5m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
17%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Liabilities
ÂĄ26.8m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fujian Cosunter Pharmaceutical Co Ltd's Other Liabilities?
Other Liabilities
277.3m CNY

Based on the financial report for Mar 31, 2024, Fujian Cosunter Pharmaceutical Co Ltd's Other Liabilities amounts to 277.3m CNY.

What is Fujian Cosunter Pharmaceutical Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
40%

Over the last year, the Other Liabilities growth was 4%. The average annual Other Liabilities growth rates for Fujian Cosunter Pharmaceutical Co Ltd have been 81% over the past three years , 40% over the past five years .

Back to Top